SCHEMBL24816166

SCHEMBL24816166

O=C(CSc1nccs1)N1Cc2cc(Cl)c(Cl)cc2C1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ FBP1 P09467 2/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ LMNA P02545 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HTR7 P34969 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ NOTUM Q6P988 3/20 0.35
▸ GRM5 P41594 1/20 0.34
▸ GAA P10253 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TAAR1 Q96RJ0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24815712 0.88 MAOB (0.41) ALDH1A1SMN1; SMN2KDM4EFBP1KMT2A
SCHEMBL24815667 0.87 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2KDM4EFBP1KMT2A
SCHEMBL24814435 0.86 HSD17B3 (0.43) ALDH1A1SMN1; SMN2KDM4EFBP1KMT2A
SCHEMBL29986261 0.84 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KDM4EKMT2ALMNA
SCHEMBL24814434 0.84 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KDM4EKMT2ALMNA
SCHEMBL26845894 0.83 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2KDM4EFBP1KMT2A
SCHEMBL24815709 0.83 NAMPT (0.44) ALDH1A1SMN1; SMN2KMT2AMEN1GAA
SCHEMBL24815708 0.80 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2KDM4EFBP1KMT2A
SCHEMBL24814400 0.79 DPP7 (0.43) ALDH1A1SMN1; SMN2KDM4EKMT2ALMNA
SCHEMBL24816150 0.79 NAMPT (0.42) ALDH1A1SMN1; SMN2KDM4EKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed
WO-2022251343-A2 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH ALDH1A1 3533/4885SMN1; SMN2 1176/4885KDM4E 4143/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH ALDH1A1 3533/4885SMN1; SMN2 1176/4885KDM4E 4143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback